Patents by Inventor Kenneth LIECHTY

Kenneth LIECHTY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250136617
    Abstract: Small molecule CXC chemokine receptor type 4 (CXCR4) agonists are disclosed, methods of their manufacture, and uses thereof, in particular to improve healing and reduce the risk of injury for wound healing in diabetes.
    Type: Application
    Filed: February 7, 2023
    Publication date: May 1, 2025
    Inventors: Kenneth Liechty, Siobhan Malany, Satyamaheshwar Peddibhotla, Carlos Zgheib
  • Publication number: 20240189347
    Abstract: The present disclosure relates to wound treatment and therapy and the promotion of tissue regeneration following injury. In particular, it relates to a microRNA-146a and nanoceria conjugate for improving wound healing and, in some embodiments, preventing adverse ventricular remodeling following myocardial infarction.
    Type: Application
    Filed: November 7, 2023
    Publication date: June 13, 2024
    Inventors: Kenneth Liechty, Sudipta Seal, Robert Gorman
  • Patent number: 11833172
    Abstract: The present disclosure relates to wound treatment and therapy and the promotion of tissue regeneration following injury. In particular, it relates to a microRNA-146a and nanoceria conjugate for improving wound healing and, in some embodiments, preventing adverse ventricular remodeling following myocardial infarction.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: December 5, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF COLORADO, UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Kenneth Liechty, Sudipta Seal, Robert Gorman
  • Publication number: 20220105200
    Abstract: Methods of treating, reducing the risk of, preventing, or alleviating a symptom of inflammation or inflammatory disease, including wounds, diabetic ulcer, and inflammatory bowel disease, by administration of gel-based delivery particles, such as zwitterionic copolymer cryogels or chitosan microgels, containing cerium oxide nanoparticles.
    Type: Application
    Filed: February 4, 2020
    Publication date: April 7, 2022
    Inventors: Kenneth Liechty, Carlos Zgheib, Melissa D. Krebs, Lindel Dewberry, Sudipta Seal
  • Publication number: 20210338718
    Abstract: Methods of treating, reducing the risk of, preventing, or alleviating a symptom of a pulmonary disease or condition, reducing or suppressing inflammation in the lung, and promoting lung repair, by pulmonary administration of a cerium oxide nanoparticle composition.
    Type: Application
    Filed: September 27, 2019
    Publication date: November 4, 2021
    Inventors: Kenneth LIECHTY, Carlos ZGHEIB, Sarah Ashley HILTON
  • Publication number: 20180344764
    Abstract: The present disclosure relates to wound treatment and therapy and the promotion of tissue regeneration following injury. In particular, it relates to a microRNA-146a and nanoceria conjugate for improving wound healing and, in some embodiments, preventing adverse ventricular remodeling following myocardial infarction.
    Type: Application
    Filed: November 23, 2016
    Publication date: December 6, 2018
    Inventors: Kenneth LIECHTY, Sudipta SEAL, Robert GORMAN